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A GOOD SCORE?: EXAMINING TWENTY
YEARS OF DRUG COURTS IN THE UNITED
STATES AND ABROAD
Kimberly Y.W. Holst
I. INTRODUCTION: WHAT‘S THE CURRENT STATE OF DRUG COURTS IN THE
UNITED STATES AND AROUND THE WORLD?
In 2009, we saw the passing of the twentieth anniversary of drug
courts1 in the United States.2 This timing presents an opportune moment
to review the state of drug courts in the United States and the
development of drug courts internationally. While the United States has


Legal Writing Faculty, Hamline University School of Law. Professor Holst would like
to thank Morgan Bianco, J.D. and Megan Jens, J.D., M.L.I.S. for their excellent research
assistance. She would also like to thank the Legal Writing Institute‘s Writers Workshop for
providing feedback and support on this article and on how to complete this type of work
within a Legal Writing professor‘s schedule.
1
Drug courts as used in this article refers to the drug treatment court model. There are
several other types of drug courts used throughout the United States and the world
including juvenile drug courts, family drug courts, and re-entry drug courts. Additionally,
this paper does not address concerns of constitutionality, collaboration, judicial discretion,
and similar concerns in the context of drug courts. See Peggy Fulton Hora & Theodore
Stalcup, Drug Treatment Courts in the Twenty-First Century: The Evolution of The Revolution in
Problem-Solving Courts, 42 GA. L. REV. 717 (2008) (discussing the many concerns that arise in
the context of drug treatment courts); Peggy Fulton Hora, William G. Schma & John T.A.
Rosenthal, Therapeutic Jurisprudence and the Drug Treatment Court Movement: Revolutionizing
the Criminal Justice System’s Response to Drug Abuse and Crime in America, 74 NOTRE DAME L.
REV. 439, 516–28 (1999) (discussing various concerns arising in drug courts).
2
Morris B. Hoffman, Commentary, The Drug Court Scandal, 78 N.C. L. REV. 1437, 1461
(June 2000). New York City is credited with using a separate court to deal with drug cases
(Narcotics Courts) in the 1970‘s. Id. at 1460. These courts were focused on managing the
number of drug cases that were being introduced and not on treatment and by the 1980‘s
these courts had taken on so many non-drug cases they had basically become traditional
courts. Id. In the late 1980‘s, these courts were reconfigured and named ―N Parts‖ and
again were focused on dealing with the sheer number of drug cases in a traditional
manner. Id. at 1460–61. See also Steven Belenko, Research on Drug Courts: A Critical Review,
1 NAT‘L DRUG CT. INST. REV. 1, 4 (1998) (discussing the birth of ―Narcotics Courts‖ in New
York); Dwight Vick & Jennifer Lamb Keating, Community-Based Drug Courts: Empirical
Success. Will South Dakota Follow Suit?, 52 S.D. L. REV. 288, 288–90 (2007) (reviewing a
history of drug courts). The first drug court with a focus on treatment was established in
Dade County, Miami, Florida in 1989. Hoffman, supra, at 1461; see also STEVEN BELENKO &
TAMARA DUMANOVSKY, BUREAU OF JUSTICE ASSISTANCE, U.S. DEP‘T OF JUSTICE, Pub. No.
NCJ-144531, SPECIAL DRUG COURTS: PROGRAM BRIEF 4 (1993); Michael C. Dorf & Jeffrey A.
Fagan, Foreword, Community Courts and Community Justice: Problem-Solving Courts: From
Innovation to Institutionalization, 40 AM. CRIM. L. REV. 1501, 1502–03 (2003); John S.
Goldkamp, The Drug Court Response: Issues and Implications for Justice Change, 63 ALB. L.
REV. 923, 923 (2000); Vick, supra, at 290; Michael Wright, Reversing the Prison Landscape: The
Role of Drug Courts in Reducing Minority Incarceration, 8 RUTGERS RACE & L. REV. 79, 88–89
(2006).
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served as a model and a leader in the creation and development of drug
courts, countries all over the world have tweaked the United States‘
model and have altered the landscape in the structure and development
of drug courts.
Part II of this Article briefly discusses the development and current
status of drug courts in the United States. Part III examines a sampling
of drug courts from around the world. Next, the article takes a look at
some of the core principles in drug treatment. The final section discusses
possible changes to the United States‘ system of drug courts based on
lessons learned from its international counterparts and from the
principles of drug treatment.
II. DRUG COURTS IN THE UNITED STATES
Over 1,200 counties in the United States operate a drug court or are
planning to establish a drug court. 3 Drug courts have been implemented
or are planned in all fifty states plus the District of Columbia, Northern
Marina Islands, Puerto Rico, and Guam. 4 Additionally, there are 111
tribal drug court programs.5 Based on these numbers, it is clear that
communities and legal systems have put their faith, if not their stamp of
approval, in drug courts.6
The treatment-focused drug court that is popular today developed in
Dade County, Florida in 1989.7 This court began in response to the
astonishingly large number of offenders with drug-related crimes.8 The
thought was that treatment or rehabilitation would serve as a way to
help deal with problems relating to substance abuse and reduce
recidivism.9 What resulted is an explosion of drug treatment courts in

BJA DRUG COURT CLEARINGHOUSE PROJECT, SUMMARY OF DRUG COURT ACTIVITY BY
STATE AND COUNTY 139 (July 14, 2009), available at http://www1.spa.american.edu/
justice/documents/2150.pdf. There are 3155 counties in the United States and 1416 have or
have plans for a drug court. This is roughly forty-five percent of the counties in the United
States. Id.
4
Id.
5
Id. For the tribal drug courts, seventy-six have been implemented and thirty-five are
in the planning stages. Id.
6
See, e.g., Trent Oram & Kara Gleckker, Comment, An Analysis of the Constitutional
Issues Implicated in Drug Courts, 42 IDAHO L. REV. 471, 478 (2006) (―Although it is difficult to
exactly measure the success and effects of drug courts, drug court is generally accepted as a
worthwhile and beneficial program.‖).
7
BELENKO & DUMANOVSKY, supra note 2, at 4.
8
Vick, supra note 2, at 289.
9
Id.
3
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the United States and in the world. It has even been termed ―the most
significant criminal justice initiative in the last century.‖ 10
While some early drug courts were viewed merely as a means of
quickly and efficiently dispatching of the growing number of drug cases
in the courts,11 this expedited model is not the model of drug courts that
stuck in the United States.12 The judiciary determined that while
expeditious case management was a goal of the drug court system, if
nothing was done to stymie the rising number of cases relating to drug
abuse, no expedited process would be sufficient to manage the excessive
caseloads.13 Instead, the courts turned to a more therapeutic form of case
management in developing the drug treatment courts.14
These drug courts focused on the treatment of the defendant‘s drug
abuse rather than the simple punishment and processing of the
defendant through the criminal justice system. 15
An important
distinguishing component of these drug courts is the adoption of the
view that addiction is a disease that requires treatment. 16 The goal then
is to reduce judicial caseloads by ―decreasing recidivism and possibly the
number of drug-related arrests in general.‖17 As such, these drug courts
necessarily approach the issues related to drug abuse as conditions
requiring therapeutic treatment.18
There are a staggering number of incarcerated adults who have
alcohol or drug abuse issues.19 Some estimates put costs associated with
this issue in the range of ―upwards of $12.9 billion per year [spent] on
illicit drug control, including police protection, the judiciary, corrections,
and related costs.‖20 The extreme number of offenders with drug abuse
problems and the increasing costs related to the offenders and offenses
ensure that some system of treating drug crimes will remain a part of the
United States judicial system in the present and in the foreseeable future.

Id. at 291 (quoting C. West Huddleson III et al., Painting the Current Picture: A National
Report on Drug Courts and Other Problem Solving Court Programs in the United States, 1 NAT‘L
DRUG CT. INST. REV. 1, 1 (2004)).
11
Hora, Schma & Rosenthal, supra note 1, at 462–63. Some expedited drug case
management courts still exist and use standard means of punishment—probation, parole—
for drug offenders. Id. at 463.
12
Id. at 425.
13
Id. at 463.
14
Id.
15
Id.
16
Id.
17
Id.
18
Id.
19
Hora & Stalcup, supra note 1, at 720. The total impact on society attributable to alcohol
and drug use was in excess of $180 billion in 2002. Id. at 721.
20
Id. These offenders also impact the cost of emergency room visits. Id.
10
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The development of drug courts in the United States has not been
without its opponents.21 Some argue that drug courts were developed as
a compromise within the therapeutic community seeking a method
focused on treatment rather than culpability. 22 Additionally, for the
courts, it presented a method to expedite case processing, requirement of
treatment, retention of traditional forms of incapacitation for failing
participants, and it avoided calls for more radical legislative change. 23
Although this is a more cynical view, it does not contradict the following
purposes indicated by drug court proponents:
addressing the
overloaded criminal courts, emphasizing therapeutic approaches to treat
addiction, reducing high expenditures resulting from the war on drugs,
providing an alternative team-focused model of criminal court,
establishing links to restorative justice, and dealing with heavy-handed
mandatory sentencing guidelines.24
Drug courts receive their authority via a state rule or statute. Since
their development in 1989, there has been an increasing focus on creating
standards for efficiently and effectively operating drug courts. This is
evident by the creation of organizations such as the National Association
of Drug Court Professionals (―NADCP‖),25 the National Drug Court
Institute (―NDCI‖),26 the Congress of State Drug Court Associations, 27
Josh Bowers, Contraindicated Drug Courts, 55 UCLA L. REV. 783, 795–96 (2008).
Id.
23
Id.
24
Candace McCoy, Commentary, Community Courts and Community Justice: The Politics
of Problem-Solving: An Overview of the Origins and Development of Therapeutic Courts, 40 AM.
CRIM. L. REV. 1513, 1518 ( 2003).
25
About NADCP, NAT‘L ASS‘N OF DRUG CT. PROFS., http://www.nadcp.org/learn/about
-nadcp (last visited Oct. 10, 2010). The NADCP focuses on reducing substance abuse, crime
and recidivism by promoting and advocating for the establishment and funding of Drug
Courts and providing for collection and dissemination of information, technical assistance,
and mutual support to association members. Id.
26
NAT‘L DRUG CT. INST., http://www.ndci.org/ndci-home/ (last visited Oct. 10, 2010).
The NDCI is a partner organization of the NADCP. Id. It was established in 1997 and
is supported by the White House Office of National Drug Control
Policy; U.S. Department of Justice, Office of Justice Programs through
the Bureau of Justice Assistance, Office of Juvenile Justice &
Delinquency Prevention, and the National Institute of Justice; U.S.
Department of Health & Human Services, Substance Abuse & Mental
Health Services Administration through the Center for Substance
Abuse Treatment; and the State Justice Institute.
Id. The mission of the NDCI is to support education, research, and scholarship for drug
court and other court-based intervention programs. About NDCI, NAT‘L DRUG CT. INST.,
http://www.ndci.org/trainings/about-ndci (last visited Oct. 10, 2010).
27
Congress of State Drug Court Associations, NAT‘L ASS‘N OF DRUG CT. PROFS.,
http://www.nadcp.org/act/policy-action-center/congress-state-drug-court-associations
(last visited Oct. 10, 2010). The Congress of State Drug Court Programs is also a division of
the NADCP. Id. ―The Congress of State Drug Court Association (CSDCA) was formed in
21
22
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and the Office of Drug Court Programs within the Office of Justice
Programs (―OJP‖) in the U.S. Department of Justice. 28 One significant
example of such standards is the Ten Key Components issued by the
Bureau of Justice Assistance of the Office of Justice Programs, U.S.
Department of Justice. The Ten Key Components are as follows:
Key Component #1: Drug courts integrate alcohol and
other drug treatment services with justice system case
processing.
Key Component #2: Using a nonadversarial approach,
prosecution and defense counsel promote public safety
while protecting participants‘ due process rights.
Key Component #3: Eligible participants are identified
early and promptly placed in the drug court program.
Key Component #4: Drug courts provide access to a
continuum of alcohol, drug, and other related treatment
and rehabilitation services.
Key Component #5:
Abstinence is monitored by
frequent alcohol and other drug testing.
Key Component #6: A coordinated strategy governs
drug court responses to participants‘ compliance.
Key Component #7: Ongoing judicial interaction with
each drug court participant is essential.
Key Component #8:
Monitoring and evaluation
measure the achievement of program goals and gauge
effectiveness.

1997 by NADCP to bring together state Drug Court Associations to assist in the
development of the national agenda for the Drug Court movement.‖ Id. ―Since that time,
the CSDCA has become the advocacy voice for Drug Court professionals. With over 30
states having their own association and serving on the CSDCA, the CSDCA plays in [sic]
integral role at both the state and federal level . . . .‖ Id.
28
Looking at a Decade of Drug Courts, NAT‘L CRIMINAL JUSTICE REFERENCE SERV.,
http://www.ncjrs.gov/html/bja/decade98.htm (last visited Sept. 24, 2010) [hereinafter
Decade of Drug Courts]. The Drug Court Clearinghouse Technical Assistance Project
(―DCCTAP‖) ―compiles operational and evaluative information on adult, juvenile and
family drug court programs throughout the United States.‖ Id.
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Key Component #9:
Continuing interdisciplinary
education promotes effective drug court planning,
implementation, and operations.
Key Component #10: Forging partnerships among drug
courts, public agencies, and community-based
organizations generates local support and enhances
drug court program effectiveness.29
The focus of the Key Components is on a non-adversarial, treatmentbased approach to handling cases dealing with drug offenders. The
offender has direct and frequent interaction with the treatment team
which includes interaction with the judge. The offender is continuously
monitored and assisted by treatment professionals as well as the court. 30
It is important to note that abstinence from drug use is a key component
of drug courts in the United States. Additionally, the key components
recognize the need to view the issues of the drug abuser in the larger
picture of the legal system. However, notably absent from the key
components is the articulated need to view the drug abuser herself in a
more holistic context—addressing the larger problems facing the drug
abuser that impact her use and recovery.31
―The core components of a drug court typically include regular
status hearings in court, random weekly urinalyses, mandatory
completion of a prescribed regimen of substance abuse treatment,
progressive negative sanctions for program infractions, and rewards for
program accomplishments.‖32 While abstinence is a key component of
most drug court treatment programs, a single finding of drug use will
Instead,
not typically result in expulsion from the program.33

BUREAU OF JUSTICE ASSISTANCE, NCJ 205621, DEFINING DRUG COURTS: THE KEY
COMPONENTS iii (1997), available at http://www.ojp.usdoj.gov/BJA/grant/DrugCourts/
DefiningDC.pdf [hereinafter THE KEY COMPONENTS]; see also Hora & Stalcup, supra note 1,
at 725.
30
THE KEY COMPONENTS, supra note 29, at iii.
31
Key component #4 suggests access to a variety of services, but does not state that
support will be provided to obtain and follow through with these services. Key component
#10 suggests that the courts will partner with other agencies. Again, the focus is on the
courts working with other agencies to run the program, rather than on the participant and
her use or support through these other agencies.
Key component #9 suggests
interdisciplinary education for the court, not the participants.
32
Douglas B. Marlowe, Integrating Substance Abuse Treatment and Criminal Justice
Supervision, SCI. & PRAC. PERSP. 4, 7 (August 2003); see also Hora & Stalcup, supra note 1, at
726–27.
33
Hora & Stalcup, supra note 1, at 762.
29
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participants may be subjected to brief periods of incarceration for failure
to comply.34
The judge in a drug court takes on a more proactive role by not only
presiding over the legal and procedural issues presented but also serving
as an enforcer of positive offender behavior. 35 While the judge takes a
central role, the team-based approach is essential to the functioning of
the drug court.36 The team typically consists of prosecutors, defense
attorneys, and drug treatment professionals working together to assist
the drug offender in overcoming their drug problems and related issues,
such as finances, employment, and related issues. 37 Offenders who
successfully complete the program may have their charges dismissed (in
a diversion or deferred prosecution model) or have their probation
period reduced or sentence suspended or deferred (in a postadjudication model).38
In theory, this approach is therapeutic and aimed at treating the
cause of the offender‘s behavior as opposed to punishing the offender for
his or her behavior. In reality, the effectiveness of these programs at
providing appropriate treatment, protecting individual rights, and
reducing recidivism has come under fire. The problem is that hard data
on drug courts is hard to come by for a number of reasons including
difficulty in determining control and target groups that provide accurate
comparisons, difficulty in determining an impact to be measured, and
differences in drug court practices and standards across the United
States.39 As a result, the available data, arguably, does not conclusively
support or discount the success of drug courts. 40
Id.
Justine Walker, International Experience of Drug Courts, SCOTTISH EXEC. CENT.
RESEARCH UNIT (2001), available at http://www.scotland.gov.uk/Resource/Doc/156630/
0042081.pdf.
36
Id.
37
Id.
38
Oram, supra note 6, at 478; U.S. GOV‘T ACCOUNTABILITY OFFICE, GAO-05-219, ADULT
DRUG COURTS: EVIDENCE INDICATES RECIDIVISM REDUCTIONS AND MIXED RESULTS FOR
OTHER OUTCOMES 36 (2005), available at http://www.gao.gov/new.items/d05219.pdf.
There are a variety of methods and reasons for adopting one model over the other (in terms
of timing entrance into the drug court program). It is important to note that pre-plea
programs get individuals into treatment faster than post-plea adjudication programs. Hora
& Stalcup, supra note 1, at 785–86.
39
Hoffman, supra note 2, at 1480.
40
Pamela M. Casey & David B. Rottman, Problem-Solving Courts: Models and Trends, 26
JUST. SYS. J. 35, 45 (2005). ―[T]he lack of scientific rigor‖ used in studies for drug courts (i.e.
reduction in jail costs, recidivism rates, retention, graduation) allows for ―proponents and
skeptics to find data in support of their positions.‖ Id. See also Hora, Schma & Rosenthal,
supra note 1, at 516–28. Skeptics of the drug court model cite a number of different reasons
for changing or eliminating the use of drug courts in the criminal justice system. Some of
34
35
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One of the central arguments against drug courts from a treatment
standpoint is that a drug court holds itself out as a therapeutic
alternative for addressing drug offenders while using traditional
punitive measures to ―treat‖ failures within the drug court system. 41
During the treatment phase, the drug user is treated as a sick patient
with crimes serving as the symptoms of his illness. 42 However, when the
participant fails to respond to treatment, his crimes are not treated as
symptoms; they convert back to the traditional paradigm of a willfully
committed crime for which punishment is doled out accordingly. 43 This
schizophrenic view of the nature of drug offenses causes internal discord
in the process and difficulty for those engaged within the process. 44

the more common concerns deal with the mixed and often confusing role of drug courts as
a mode of therapy, but enforced with traditional punitive techniques for failures,
safeguarding the rights of participants throughout the drug court process, and the
requirement of judges and defense attorneys to assume non-traditional and arguably
contradictory roles throughout the process. See, e.g., Hora, Schma & Rosenthal, supra note
1, at 508–35. Additionally, drug court statistics are frequently cited as being biased or
incomplete, allowing for easy manipulation to suit proponents‘ purposes. See, e.g., Casey,
supra note 40, at 45; Michael Rempel et al., Drug Courts an Effective Treatment Alternative, 19
CRIM. JUST. 34 (Summer 2004).
41
See, e.g., Bowers, supra note 21, at 788; Hoffman, supra note 2, at 1470–73; Dawn Moore,
Translating Justice and Therapy: The Drug Treatment Court Networks, 47 BRIT. J. CRIMINOLOGY
42, 44 (January 2007).
42
Bowers, supra note 21, at 788.
43
Id.
44
There are other concerns with drug courts addressed in depth in other law review
articles. A number of the concerns relate to safeguards for the individual rights of the
individual participants within the drug court paradigm. Oram, supra note 6, at 472–73; see
also, e.g., Bowers, supra note 21, at 803–05. For example, concerns arise related to equal
protection and access to drug courts when drug courts are not available uniformly
throughout the country (this is viewed in the U.S. Constitutional aperture, but may also be
applied in the international context as no country has developed a thorough and uniform
system of drug courts throughout the whole of the country). Oram, supra note 6, at 480–85.
Cases involving the question of equal protection have generally found that drug courts do
not violate the offender‘s equal protection rights because treatment is not viewed as a
fundamental right and drug users do not constitute a suspect class. Id. at 482–83.
Additionally, drug courts pass the rational relationship test because they are rationally
related to a legitimate state objective. Id. The next individual right implicated in the drug
court context has to do with due process rights in the entry process. It has been argued that
the complex nature of drug court plea bargains make it difficult for a defendant to enter the
plea knowingly and intelligently, that a number of due process rights must be understood
and waived, and that the lack of alternatives to entering a drug court plea result in a
coercive setting where the defendant sees the drug court plea as the only rational option.
Id. at 492–518; see also Bowers, supra note 21, at 802–03. Most of these concerns are or can be
addressed by the standards put in place to govern plea bargains and ethical conduct by the
defense attorney and prosecution, as long as each of the actors is aware of the rights
implicated. Oram, supra note 6, at 518–19.
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Despite these concerns, existing statistical and anecdotal evidence
suggest that drug courts are successful in achieving their stated goals. 45
Fiscal savings, treatment success, and reduced rates of recidivism are all
used to demonstrate the success of drug courts. 46 According to the Drug
Court Clearinghouse Technical Assistance Program (―DCCTAP‖) in a
1998 report reviewing the first ten years of drug courts in America, drug
courts have been extremely successful in reducing recidivism by drug
users (particularly for drug court graduates), providing increased
monitoring and treatment supervision and promptly dealing with
relapse and other issues related to long-term treatment.47 Furthermore,
drug courts have been able to achieve high numbers of retention, better
results for families and children of participants, cost-savings, more time
for courts to deal with violent and other criminal cases, the provision of
other necessary treatments (such as mental health and physical health),
and significant growth and organization of programs around the
country.48 Additionally, stories reflecting the positive benefits of drug
courts are effectively used to tout the benefits of drug courts in the
legislature and in the media.49

See Hora, Schma & Rosenthal, supra note 1, at 502–08 (―[Drug courts] across the
country have recorded substantial success in retaining participants in treatment programs,
reducing recidivism rates, and saving criminal justice system resources.‖).
46
Id.
47
Decade of Drug Courts, supra note 28.
48
Id.
49
See Kevin Behr, Wabasha County Drug Court is Turning Around People’s Lives, WINONA
DAILY NEWS, June 22, 2008 (describing the story of a Minnesota drug court participant who
credits the drug court with changing her life). The participant had been addicted to alcohol
and methamphetamines for over twenty years when she was admitted into drug court. Id.
She had been in and out of court-ordered treatment several times and had served time in
jail in the past. Id. At the time she entered drug court, she was facing seven years in prison
and her two children had been placed in foster care. Id. As a participant in the drug court
program, she was able to overcome a life of addiction, keep her children, and stay out of
prison. Id. She has remained clean and sober for over four years. Id. She attributes her
success to the supervision and support she received while in the drug court program. Id.;
see also innovation Research & Training, Inc., Durham County Adult Drug Treatment Court
Process Evaluation Report 93 (2005), available at http://www.nccourts.org/Citizens/
CPrograms/DTC/documents/durham_adultdtc_eval_final.pdf
[hereinafter
Durham
County Report]. This report was based on a comprehensive study of Durham County Drug
Court, a court-supervised, post-plea drug treatment court administered by North Carolina
Administrative Office of the Courts. Durham County Report, supra, at 92. ―Both team
members and participants report that the program has had a significant positive impact on
the lives of participants, including the reduction or elimination of drug and/or alcohol use,
improved family relations, and improved financial and employment stability.‖ Id. at 93.
Arguably, success stories like the ones described above have a more powerful and lasting
impact on lawmakers and community members than any statistical data that can be
provided.
45
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Despite the arguments in favor of drug courts, these courts will
continue to face challenges in the future. Perhaps the most urgent is that
the current economic situation has put pressure on court systems across
the country to cut costs, and drug courts could end up on the chopping
block in a number of jurisdictions. 50
III. SURVEY OF DRUG COURTS AROUND THE WORLD
In addition to tremendous growth in the number of drug courts in
the United States, drug courts have developed at an astonishing rate
across the globe. The first drug court outside of the United States
became operational in Toronto, Canada, on December 1, 1998. 51 Courts
have continued to develop in countries as diverse ―as Australia, Jamaica
and Ireland. [Additionally, t]here are currently drug treatment courts
operating or planned in Brazil, Cayman Islands, Bermuda, Trinidad,
Barbados, New Zealand, Scotland, Norway, Italy, and Macedonia.‖ 52
According to the International Association of Drug Treatment Courts
(―IADTC‖), there are approximately fifteen countries using or planning
to use a system of drug courts around the world. 53 Additionally, a
number of other countries are using other systems of diversion to
address the growing number of drug-related cases that are backing up
their justice systems.54 And still, the leadership in other countries is
calling for the formation of specialized drug treatment courts where
none currently exist.55 While programs in countries other than the U.S.
are still largely in their formative stages, the majority of the feedback
from the individual programs is positive. The countries report various

One illustration of this situation can be seen in Minnesota where courts are facing
several millions of dollars in cuts to their budgets. See Patrick Thornton, Courts Express
Concern Over Minnesota Governor’s Proposed Funding Cut, THE MINN. LAW., Feb. 22, 2010
(stating that staffing and funding for ―programs aimed at reducing recidivism, like drug
courts, will be discontinued‖).
51
About the IADTC, INT‘L ASS‘N OF DRUG TREATMENT COURTS, http://www.iadtc.law.
ecu.edu.au/about/index.html (last visited Sept. 24, 2010).
52
Id.
53
Id. These countries include: England, Canada, Australia, New Zealand, Jamaica,
Ireland, Brazil, Cayman Islands, Bermuda, Trinidad, Barbados, Scotland, Norway, Italy,
and Macedonia. Id.
54
See Michael S. King, Magistrate, Perth Drug Court, Challenges Facing Australian
Court Drug Diversion Initiatives, Keynote Address at the Court Drug Diversion Initiatives
Conference (May 25–26, 2006) (transcript available at http://www.aic.gov.au/events/
aic%20upcoming%20events/2006/drugdiversion.aspx).
55
See Michael Punongbayan, Dangerous Drugs Board Calls for Creation of Special Drug
Courts, THE PHIL. STAR, Jan. 18 2010, available at http://www.philstar.com/Article.aspx?
articleId=541754&publicationSubCategoryId=63 (stating that the board on dangerous
drugs calls for the formation of drug treatment courts in the Philippines).
50
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benefits, such as increased collaboration between agencies providing
services to participants,56 better support options for participants,57
reduced rates of recidivism,58 and cost-savings.59 This section gives a
brief survey of drug courts from different areas of the world.
A. Canada
About a decade after drug courts began in the United States, the first
drug court opened its doors in Canada.60 Toronto‘s drug treatment court
opened its doors in December 1998.61 Six drug treatment courts are
currently operating in Canada.62 These courts include: Edmonton
(December 2005), Winnipeg (January 2006), Ottawa (March 2006), and
Regina (October 2006), in addition to the existing drug treatment courts
that continue to operate in Toronto (December 1998) and Vancouver
(December 2001).63 ―All of these programs, as a condition of their
funding, are responsible for developing site-specific results-based
evaluation/accountability frameworks, as well [as] contributing to the
national evaluation/accountability framework.‖ 64
The drug court pilot program began in Canada in 1998. 65 The
program is based in Toronto and is aimed at prostitutes, youth, and
identifiable minorities, but does allow for other drug offenders with
eligible offenses to be a part of the program. 66 In contrast to the U.S.
model, which favors abstinence from all drug use, the Toronto Drug
Treatment Court uses a harm-reduction model.67 Therefore, use of
illegal drugs while participating in the program will not result in
56
Drug Court, COURTS ADMIN. AUTH. S. AUSTL. (Aug. 12, 2009) http://www.courts.sa.
gov.au/courts/drug_court/index.html [hereinafter S. AUSTL.].
57
Id.
58
Facts on Drug Courts, CONSULATE GEN. OF THE U.S. SAO PAOLO BRAZ.,
http://www.embaixada-americana.org.br/index.php?action=saopaulomateria.php&id=
8455&submenu=14&itemmenu=165 (last visited Sept. 24, 2010) [hereinafter BRAZIL].
59
Expanding Drug Treatment Courts in Canada, DEP‘T OF JUSTICE CAN.,
http://www.justice.gc.ca/eng/news-nouv/nr-cp/2005/doc_31552.html (last visited Sept.
24, 2010); see also BRAZIL, supra note 58.
60
Expanding Drug Treatment Courts in Canada, supra note 59.
61
Id.
62
Drug Treatment Court Funding Program, DEP‘T OF JUSTICE CAN., http://www.justice.gc.
ca/eng/pi/pb-dgp/prog/dtc-ttt/index.html (last visited Sept. 24, 2010).
63
Id.
64
Id.
65
Walker, supra note 35, at 24.
66
Id.
67
Id.; see also Drug Treatment Court Funding Program, supra note 62 (explaining that the
Canadian model is aimed at reducing the harm people cause to themselves and to others
through their drug use, as well as reducing the risk that these individuals will continue to
use drugs and thereby come into conflict with the law).
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sanctions.68 Instead, the participant is successful when he or she has
achieved a positive lifestyle change such as stopping cocaine or heroin
use, but occasionally using marijuana or alcohol.69 When they complete
the program, these participants may still be on a probationary period
and will be expected to end all illegal drug use. 70
While the ultimate goal is not necessarily abstinence but rather harm
reduction, the principles that govern Canadian drug courts are very
similar to those in the United States. ―Drug Treatment Courts aim to
reduce crime committed as a result of drug dependency through courtmonitored treatment and community service support for offenders with
drug addictions.‖71 The Canadian model draws a great deal from the
U.S. Drug Court model in other respects. The Canadian model uses a
two-track method for entering offenders into the program. The first
track allows offenders with little or no criminal record and a charge of
possession of a controlled substance to enter the program without a plea
in a deferred sentencing model. Offenders with a more serious criminal
record and/or charges of drug trafficking are moved into track two,
which requires the offender to enter a plea in a post-adjudicative
model.72
Additionally, Drug Treatment Courts ―aim to reduce the burden of
substance abuse on the Canadian economy.‖ 73 The estimated annual
impact of substance abuse on the Canadian economy, including costs
related to law enforcement, prosecution, and incarceration, is estimated
at $9 billion.74
The structure of the drug treatment court program is that of an
outpatient program.75 The participants attend individual and group
counseling sessions.76 The participants receive appropriate medical
attention, which may include methadone treatment, and are subject to
random drug tests.77
Like in the United States, participants are required to make regular
court appearances and the court has the ability to impose sanctions for
failure to comply with the program requirements. 78 These sanctions can

68
69
70
71
72
73
74
75
76
77
78
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range from verbal reprimands to expulsion from the program. 79 The
judge can also provide rewards for compliance such as verbal
commendations or reducing the number of required court appearances.80
Community partners also address the participant‘s other basic needs
―such as safe housing, stable employment and job training.‖ 81 Success in
the program is achieved when the participant attains a level of social
stability and can demonstrate a level of control over his or her
addiction.82 At that time, the criminal charges may be stayed or the
participant may receive a non-custodial sentence.83
B. Australia
Australia implements two main alternatives to conventional
sentencing when addressing drug-related offenses: drug courts and
court diversion programs.84 Drug courts typically address more serious
offenders and require a more intense program with longer time frames
and follow similar frameworks to U.S. drug courts. 85 Court diversion
programs tend to deal with less serious offenses, and there is often less
or no involvement by the court in the management of the offender‘s
treatment.86
Australia‘s drug diversion programs have been a part of its judicial
system for over thirty years, while drug courts are a relatively new
development with the first such court established in 1999.87 Australian
drug courts use a harm-reduction model for its participants. 88 In
Australia, as in the United States, drug courts developed out of a need to
Id.
Id.
81
Id.
82
Id.
83
Id. ―[S]tayed (meaning a judgement [sic] is suspended or postponed) or the offender
receives a non-custodial sentence (meaning restrictions other than jail, including house
arrest).‖ Id.
84
King, supra note 54, at 1. Courts in the United States have also used diversionary
sentencing as a means of addressing drug offenders, but this is done at the discretion of the
court and not within a structured program.
85
Id.
86
Id.; see also TIM MCSWEENEY, ET AL., CRIMINAL POLICY RESEARCH UNIT, REVIEW OF
CRIMINAL JUSTICE INTERVENTIONS FOR DRUG USERS IN OTHER COUNTRIES 2 (2002) (stating
that diversion at the point of arrest is commonly used throughout Australia but that little
research has been collected on the effectiveness of these schemes). The diversion program
in Australia is somewhat more akin to the expedited drug case management courts that
exist in the United States.
87
King, supra note 54, at 2.
88
Drug Court, DEP‘T OF JUSTICE VICT., AUSTL., http://www.justice.vic.gov.au/wps/
wcm/connect/DOJ+Internet/Home/Courts/Victorian+Courts/JUSTICE+-+Drug+Court
(last visited Sept. 24, 2010) [hereinafter DEP‘T OF JUSTICE VICT.].
79
80
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address the unique nature of drug addiction and the vast number of
related cases entering the courts. 89 Similar to the United States,
Australian drug courts are state initiatives and vary from state to state
but are dependent on federal funding. 90 This has resulted in an
increased need for better planning, better communication, and better
integration of existing programs as drug courts continue to grow and
develop throughout the country.91
The drug court program that the participant undergoes in Australia
may consist of a number of different stages.92 The participant is taken
through a withdrawal management program, which may include inpatient detoxification if necessary and pharmacological treatment, such
as methadone, as needed.93 Relapse prevention is provided in the form
of individual counseling or group therapy. 94 Group therapy and
individual counseling may also be employed to assist with developing
―pro-social thoughts and behaviours.‖95 Other measures may include
prevention of additional offenses through restricted bail, referral to other
agencies to assist with the management of physical and mental health
issues, education and vocational training, temporary housing for up to
fifteen months and referral to access long-term housing, assistance to
restore familial relationships, referrals to other agencies to obtain income
support and to manage financial issues, support to find or maintain
employment, and practical assistance for those leaving detention in the
form of basic personal and food items until other support can be
arranged.96 The Australian drug courts even set aside funding to
purchase services where none may exist. 97
This holistic view of treatment exemplifies a model of harm
reduction. By focusing on rehabilitation, the Drug Courts‘ treatment
program represents a fundamental shift in the way courts deal with drug
offenders. ―The ultimate goal of the program is to address drug
dependency, bring stability to offenders‘ chaotic lifestyles and break the
cycle of offending.‖98
In Australia, ―[one] report emphasizes [sic] the positive benefits
experienced by drug court participants who embrace the opportunity for
89
90
91
92
93
94
95
96
97
98
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rehabilitation. Successful offenders consistently report a large decline in
their criminal activity and lower rates of recidivism than those who were
unsuccessful or those who were sent to prison.‖99
C. England/Wales
Drug courts in England and Wales first began to appear in 1997. 100
There were a number of different models established, including some
referral or diversion schemes provided at arrest that allow for drug
offenders to enter treatment voluntarily. 101 On the basis of the success of
the early drug courts in England and in other countries such as the
United States and Scotland as well as the growing costs of drug abuse
and acquisitive crime, England started a Dedicated Drug Court pilot
model in February 2005 to evaluate the benefits and costs of the system
before wider implementation of the model. 102 English research based on
programs from other countries found that a holistic approach toward
drug treatment can offer benefits, such as increased engagement and
improved chances for completion of treatment resulting in a reduction of
drug usage and related offenses. 103
The Dedicated Drug Courts operated with five distinguishing core
characteristics as follows:


Specialism: the DDC exclusively handles cases
relating to drug-misusing offenders from conviction
through sentence, to completion or breach of their
orders.



Continuity: the DDC will try to ensure sustained
continuity of magistrates‘ bench or district judge
throughout the period an offender comes before the
DDC.

JASON PAYNE, AUSTRALIAN INSTITUTE OF CRIMINOLOGY, THE QUEENSLAND DRUG
COURT: A RECIDIVISM STUDY OF THE FIRST 100 GRADUATES, 2008 RES. & PUB. POLICY SERIES
83, at iii, available at http://www.aic.gov.au/documents/7/C/C/%7B7CCCCFD2-FFF64DAB-B17F-49700902BC1D%7Drpp83.pdf.
100
MINISTRY OF JUSTICE, RESEARCH SERIES 7/08, DEDICATED DRUG COURT PILOTS: A
PROCESS REPORT 2 (2008), available at http://www.justice.gov.uk/docs/dedicated-drugcourts.pdf.
101
MCSWEENEY, supra note 86, at 2.
102
MINISTRY OF JUSTICE, supra note 100, at iii. ―Drug misuse is estimated to give rise to
social and economic costs of between £10 and £18 billion per year.‖ Id. at 1.
103
Id. at 9.
99
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Training: sentencers and other court staff receive
additional training on working with drug-misusing
offenders and the DDC model.



Processes: processes are designed to ensure all
necessary information is before the court when
required.



Partnership: the DDCs are designed to ensure
effective multidisciplinary working with other
criminal justice system agencies and professionals. 104

The goal is that through the Dedicated Drug Court pilots, the court
would better understand the needs and motivations of the offenders,
which will result in more effective sentencing, greater participation in
treatment, and higher levels of sentence completion. 105
On the basis of the information gathered from this pilot program,
England and Wales have established a clear plan for implementing
Dedicated Drug Courts in a greater number of locations. 106 Among the
chief concerns are establishing a proper location for the courts,
determining likely number of participants for the area, adequate and
specialized training, and making sure the court is properly staffed and
that there are adequate physical accommodations and resources to
successfully implement the court.107 While the Dedicated Drug Courts
are relatively new, the early studies of these courts have indicated
success in the development of the courts and in the results for
participants in the courts.108
D. Scotland
The first drug court in Scotland was established in October 2001 in
the Glasgow Sheriff‘s Summary Court.109 The Glasgow Drug Court is
Id. at iv.
Id.
106
Id. at 43.
107
Id. at 43–46.
108
See Review of the Effectiveness of Specialist Courts in Other Jurisdictions, HOME OFFICE
CRIME REDUCTION, http://webarchive.nationalarchives.gov.uk/20100413151441/http:/
www.crimereduction.homeoffice.gov.uk/criminaljusticesystem15.htm (last visited Sept.
24, 2010) (listing the findings and conclusions of a study on the effectiveness of specialist
courts).
109
The Glasgow Drug Court in Action: The First Six Months, THE SCOTTISH GOV‘T,
http://www.scotland.gov.uk/publications/2002/11/15741/12688 (last visited Sept. 24,
2010).
104
105
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focused on adult offenders who are age twenty-one or older, and who
have ―an established relationship between a pattern of serious drug
misuse and offending and whose drug misuse is susceptible to
treatment.‖110 The offenders must be facing prosecution in court and
normally first appear in the summary court from custody.111
The drug court staff consists of the Drug Court Sheriffs, the Sheriff
Clerk, the Drug Court Procurator Fiscal (identifies potential referrals and
deals with new charges and breaches of drug court orders), and the
Project Leader of the Drug Court Supervision and Treatment Team. 112
―A Drug Court Co-ordinator facilitates the work of the Drug Court
Team.‖113
Initial referrals to the Drug Court were dependent on the arresting
officers‘ knowledge of and enthusiasm for the program.114 Despite this,
the program appeared to be identifying appropriate candidates for the
program.115 Sentencing options within the Drug Court were similar to
those available in summary court; however, there appeared to be greater
flexibility and dialogue during the sentencing in the Drug Courts. 116
Scotland also employs a harm-reduction model, which includes the use
of methadone treatment to help participants wean off of drug use. 117 The
initial findings have been positive in regard to the success of the first
drug court pilot; the following areas have been identified as potential
problems: police contribution in the referral process, need for a broader
range of rewards and sanctions, workload of treatment team members,
and team work among the multi-disciplinary professionals.118 The
Scotland drug courts also find support in the fact that other problems
facing drug court participants, such as housing, benefits, and child care,
are funded by other agencies within the country, while drug courts in
the United States tend to provide the funding for these support
services.119

Id.
Id.
112
Id. The Drug Court Supervision and Treatment Team consists of a Drug Court
Medical Officer, a senior social worker, a senior dedicated worker from Phoenix House, the
voluntary organization contracted to provide treatment services, a representative of the
police, and a representative of the Glasgow Bar Association. Id.
113
Id.
114
Id.
115
Id.
116
Id.
117
MINISTRY OF JUSTICE, supra note 100, at 16.
118
See Glasgow Drug Court in Action, supra note 109.
119
Walker, supra note 35, at 30.
110
111
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The success of the program has encouraged the Scottish government
to continue funding drug courts after the initial pilot. 120 While there has
been some concern that high numbers of participants are reconvicted
after participation in the program, evidence suggests that participants
who complete the full treatment prescribed in the drug court sentencing
are reconvicted at a much lower rate than those who breached their
order or had their orders revoked. 121
E. Ireland
In Ireland, the Drug Treatment Court was established in Dublin in
2001.122 Like England, the Irish courts began with a pilot program. This
pilot court started in Dublin North Inner City. 123 The focus of the court
was to treat rather than imprison drug users. 124 Only non-violent
offenders motivated by addiction (as opposed to financial gain) are
admitted to the program.125 The program aims to provide long-term
supervised treatment with the central principle of the program to deal
with or eliminate the addiction thereby eliminating the need to offend. 126
The pilot program was extended in 2003 for a longer period of time and
to an expanded target area.127 In 2006, the program was expanded to
include the city of Dublin.128

See Drug Courts’ Three-Year Extension, BBC NEWS (Mar. 30, 2006, 13:46 GMT),
http://news.bbc.co.uk/2/hi/uk_news/scotland/4860874.stm (reporting that drug courts
were granted a three year extension in 2006). ―Drug courts allow us to continue to develop
intensive interventions to help people with complex and deeply entrenched drug problems
to turn their lives around and turn their backs on crime.‖ Id.
121
Review of Glasgow and Fife Drug Courts: Report, CMTY. JUSTICE SERVS. SCOTTISH GOV‘T
1317, http://www.scotland.gov.uk/Resource/Doc/299438/0093354.pdf (last visited Sept.
24, 2010). ―It is encouraging that those who had an early discharge, or who had completed
their Order, had a lower reconviction rate compared to those who had breached or been
revoked. This appears to suggest that those with the resolve to complete their Order, also
committed less subsequent crimes.‖ Id. at 14.
122
INFO. OFFICE, COURTS SERV., PUB. INFO. LEAFLET, THE DRUG TREATMENT COURT 2 (Feb.
2005), available at http://www.courts.ie/Courts.ie/library3.nsf/(WebFiles)/DA10E72CEB
411A0E80257297005BD8C9/$FILE/Drug%20Treatment%20Court%20-%20public%20info.
pdf [hereinafter PUBLIC INFORMATION LEAFLET].
123
About the Courts, COURTS SERV. OF IR., http://www.courts.ie/courts.ie/Library3.nsf/
pagecurrent/10646F81427562D480256DA9004139B7 (last visited Sept. 25, 2010). Dublin
North Inner City was chosen as the target area for the pilot stage of the project. Id. ―This
decision was influenced by the greater availability of treatment programmes in that area
than in the rest of the Eastern Health Board region.‖ Id.
124
Id.
125
Id.
126
Id.
127
Id.
128
Id.
120
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The Irish also use a harm-reduction model and the program operates
in three phases.129 The first phase is called Stabilization and Orientation
and is aimed at reducing the participant‘s use of drugs and becoming
involved in a treatment and education program.130 Phase two is called
Consolidation and Progression, and the goal of this phase is to have
participants tackle specific areas of their lives that need improvement,
such as having a plan for future employment, and to continue education
and treatment from the first phase.131 Finally, phase three is called ReIntegration and Self-Management, wherein the participant is responsible
for taking full control of the positive changes in his or her life and for
maintaining a reduction in drug use.132 The participant should also have
developed strategies for stress management and self-control.133 Upon
successfully completing all phases of the program, the participant
graduates from the Drug Treatment Court program.134
F.

Jamaica

Drug courts have been established in Kingston and Montego Bay
over the last couple years.135 Jamaica is the first Caribbean country to
develop a drug court program.136 The participants in the Jamaican drug
courts are admitted based on offense (drug-related) and level of
motivation.137 On the basis of the level of motivation and assessment of
the individual‘s likelihood of success, the participant may be placed in
an inpatient (residential) treatment program or an outpatient program. 138
The program teaches the participants about the psychology and
physiology of addiction, as well as enforces social skills of punctuality
and a groomed appearance.139 An early study of the Jamaican drug
courts have reported that drug courts have helped to address social ills

129
Drug Court Treatment Programme, COURTS SERV. OF IR., http://www.courts.ie/offices.
nsf/lookuppagelink/5C3FCB8E070ADAA280256E7B003B1D9F (last visited Sept. 25, 2010).
130
PUB. INFO. LEAFLET, supra note 122, at 3.
131
Id.
132
Id. at 4.
133
Id.
134
Id.
135
L. Linton & L. Mendez, Drug Abuse Offenders Get Second Chance, JAM. INFO. SERV., Dec.
25, 2007, http://www.jis.gov.jm/justice/html/20071225t190000-0500_13871_jis_drug_
abuse_offenders_get_second_chance.asp.
136
Id.
137
Id.
138
Id.
139
Id.
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related to drug abuse and crime.140 There is additional anecdotal
evidence to support the success of drug courts in Jamaica.141
G. Brazil
Brazil has adopted a system referred to as therapeutic jurisprudence
to implement its drug courts.142 The drug court program in Brazil
―supports any program that intends to reduce harm to the drug
user/dependent‘s health, in as much as he does not contemplate the
replacement of one illicit drug with another, due to the simple fact that
involvement with illicit drugs is illegal.‖ 143 This concept of therapeutic
jurisprudence is a new paradigm that focuses on eliminating the drug
problem in Brazil and has been widely supported by various
governmental departments and other organizations. 144 Studies in Brazil
have found that drug courts not only lower crime rates, but they also
provide a cost-savings to the public.145

Regional Drug Treatment Courts Yielding Positive Results, Says OAS Study, JAM.
OBSERVER, Apr. 30, 2010, http://www.jamaicaobserver.com/news/-p-Regional-drugtreatment-courts-yielding-positive-results--says-OAS-study--p-- (―[T]he study presents a
positive picture of what drug treatment courts in the countries involved have accomplished
in providing treatment to local populations and in addressing the social ills and costs of
drug abuse and crime.‖); see also CARIBBEAN DRUGS: FROM CRIMINALIZATION TO HARM
REDUCTION 83 (Axel Klein, Marcus Day & Anthony Harriot eds., 2004).
141
Linton & Mendez, supra note 135. One story from a drug court in Jamaica refers to the
program as a life changing experience. Id. The participant states, ―It help mi fi stop drink
and stop smoke, so I find my life better off and everything change, so I‘m a new person
now. I think it help me a lot, because I‘m 40 now and I‘ve been smoking since I‘m 14 years
old.‖ Id. This participant wanted to see the program to its completion so that he could be
rehabilitated. Id. He advises, ―I can tell all the youth dem out there wha smoking the weed
and making trouble, if they could find somebody to introduce them to [drug court] to help
them, it would be better off for them to stop smoking, we would be a better country, less
violence and everything.‖ Id.
142
Carmen Silvia Có Freitas & Ricardo de Oliveira Silva, Therapeutic Jurisprudence Applied
in Brazil: “Therapeutic Justice” (DTC) The Brazilian Program for Drug Users Offenders,
ASSOCIAÇÃO BRASILEIRA DE JUSTIÇA TERAPÊUTICA, http://www.abjt.org.br/index.php?
id=59 (follow ―ARTICLES‖ hyperlink) [hereinafter ASSOCIAÇÃO].
143
Id.
144
Id. ―[I]t has received unconditional support from the National Penitentiary and
Criminal Politics Council, Brazilian Association of Alcohol and Other Drug Studies,
Department of Legal Psychiatry of the Federal Medicine School Foundation, as well as
from other mental health professionals in the country.‖ Id.
145
BRAZIL, supra note 58. Seventy-five percent of drug court graduates remain arrest-free
two years after leaving the program. Id. Drug courts reduce crime rates more than thirtyfive percent over other sentencing options. Id. Additionally, for every dollar spent on drug
courts, the taxpayer saves $3.36. Id. Overall, $4,000 to $12,000 is saved on drug court
clients. Id.
140
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The program has been applied to both juveniles and adults and can
begin at any stage of the criminal prosecution process. 146 The program
may include treatment through public or private services. Again, the
program casts a wider net than simply examining the participant‘s drug
addiction. The program looks at the socioeconomic conditions and
support networks when designing treatment options.147
IV. DRUG TREATMENT MODELS
A. Background Information About Drug Treatment
There is no consensus regarding the best course of treatment for
drug addiction. Theorists have come up with some basic precepts about
addiction that form the basis for how drug treatment is approached in
the United States and around the world. 148
It is important to understand that the degree of severity of substance
abuse ranges on a continuum and is different for each abuser. 149 The

ASSOCIAÇÃO, supra note 142.
Id.
148
See William R. Miller & Kathleen M. Carroll, Drawing the Science Together: Ten
Principles, Ten Recommendations, in RETHINKING SUBSTANCE ABUSE: WHAT THE SCIENCE
SHOWS, AND WHAT WE SHOULD DO ABOUT IT 294–301 (William R. Miller & Kathleen M.
Carroll eds., 2006) (discussing ten principles of drug use addiction). Miller and Carroll list
ten principles derived from scientific study. Id. at 294. 1. ―Drug Use Is Chosen
Behavior‖—intentional change plays a prominent role in drug treatment. Id. at 294–95. 2.
―Drug Problems Emerge Gradually and Occur along a Continuum of Severity‖—drawing
lines at different stages of addiction such as abuse and dependence may lead to arbitrary
cut points. Id. at 296. 3. ―Once Well Established, Drug Problems Tend to Become SelfPerpetuating.‖ Id. at 296. 4. ―Motivation is Central to Prevention and Intervention‖—
choice/decision point. Id. at 297. Personal commitment is a component of this principle.
Id. 5. ―Drug Use Responds to Reinforcement‖—using drugs is a form of providing the
user with positive reinforcement so the elimination of use eliminates one way the user has
to give reinforcement. Id. at 298.
Some effective medications reduce the reward value of drug use,
which can enhance the appeal of alternative reinforcers. Maintenance
medications that successfully compete with preferred drug use offer
reinforcement that is longer lasting but less intense than that obtained
from drugs of abuse. Providing clear incentives for abstinence often
yields rapid reductions in drug uses.
Id. 6. ―Drug Problems Do Not Occur in Isolation, but as Part of Behavior Clusters.‖ Id. at
298–99. 7. ―There Are Identifiable and Modifiable Risk and Protective Factors for Problem
Drug Use.‖ Id. at 299. 8. ―Drug Problems Occur within a Family Context.‖ Id. at 300. 9.
―Drug Problems Are Affected by a Larger Social Context.‖ Id. at 30001. 10. ―Relationship
Matters.‖ Id. at 301.
149
ARNOLD M. WASHTON & JOAN E. ZWEBEN, TREATING ALCOHOL AND DRUG PROBLEMS
IN PSYCHOTHERAPY PRACTICE: DOING WHAT WORKS 24 (2006).
146
147
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continuum is as follows: experimental use occasional use regular use
circumstantial or situational use binge use abuse dependence.150
There are a number of factors that complicate the treatment of drug
abuse. One complication is the concurrent existence of other mental
disorders.151 Additionally, addiction to multiple drugs is becoming more
prevalent and presents an additional problem in successful treatment of
―polydrug addiction‖ and ―polypharmacy in treatment.‖ 152 Other
factors also alter the nature of a user‘s substance abuse problem. These
include family substance abuse, generational differences, child abuse,
emotional disorders, peer pressure, and media influences. 153 Specialized
services are often necessary to address the significant problems in other
areas of the participants‘ lives like health issues, family issues,
employment, and related issues.154
The assessment of a user‘s substance abuse problems is complex and
should consist of a variety of measures.155 After the issues facing a drug
user have been identified, the treatment may proceed with any range of
therapies. These therapies may include: brief and early intervention,
teaching problem-solving skills, drink and drug refusal skills,
assertiveness skills, communication skills, cognitive therapy, relaxation
training, behavioral self-management, involving concerned others,
pharmacotherapies, self-help groups, and continuing care.156
Success of treatment is also dependent upon a number of outside
factors. Two of the variables in success after treatment are a continued
exercise program and satisfactory living arrangements after treatment

Id. at 24–26.
CARLTON K. ERICKSON, THE SCIENCE OF ADDICTION: FROM NEUROBIOLOGY TO
TREATMENT 177 (2007). Examples of conditions that are frequently associated with drug
abuse include chronic pain, Parkinsonism, schizophrenia, clinical depression, anxiety and
panic disorders, ADHD, OCD, and PTSD. Id.; see also Durham County Report, supra note 49,
at 93 (finding that in the Durham County drug courts challenges existed in finding the
right treatment and eligibility for participants when other mental health concerns were
present in participants).
152
GENNARO OTTOMANELLI, ASSESSMENT AND TREATMENT OF CHEMICAL DEPENDENCY
152 (2001).
153
Id. at 158–63.
154
A. Thomas McLellan, What We Need Is a System: Creating a Responsive and Effective
Substance Abuse Treatment System, in RETHINKING SUBSTANCE ABUSE: WHAT THE SCIENCE
SHOWS, AND WHAT WE SHOULD DO ABOUT IT 284–85 (William R. Miller & Kathleen M.
Carroll eds., 2006).
155
ROBERT D. MARGOLIS & JOAN E. ZWEBEN, TREATING PATIENTS WITH ALCOHOL AND
OTHER DRUG PROBLEMS: AN INTEGRATED APPROACH 91 (1998).
156
TRACEY J. JARVIS, JENNY TEBBUTT, RICHARD P. MATTICK & FIONA SHAND, TREATMENT
APPROACHES FOR ALCOHOL AND DRUG DEPENDENCE: AN INTRODUCTORY GUIDE vii–viii (2d
ed. 2005).
150
151
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and living with family and continuing with an after-care plan.157 There
are also negative predictors which indicate that treatment is not likely to
be successful such as socioeconomic status, financial problems related to
alcohol, and ongoing emotional distress. 158
Challenges also exist when participants are subjected to treatment
when there is no personal desire on the part of the participant to be in
treatment.159 Data suggests that ―the great majority of those who do go
to treatment have been pressured or forced into that treatment by their
spouse, employer, the legal system, or the welfare system.‖ 160 Couple
that with the fact that ―[e]ven with the threat of punishment hanging
over their heads, the great majority of those who enter substance abuse
treatments leave prematurely.‖161 This is particularly problematic in the
context of drug courts where, arguably, all of the participants are there
based on external pressures. The unfortunate reality ends up being that
―more than half of those who complete the recommended duration of
addiction treatment relapse to alcohol and drug use within 6 months
following their discharge.‖ 162
Generally, drug treatment can be looked at in three different phases:
detoxification or stabilization, rehabilitation, and continuing care. 163 In
the first phase, the treatment team prepares an unstable patient to do
well in the subsequent rehabilitation phase. 164 Detoxification alone is
unlikely to be sufficient to set a participant on a lasting course of
recovery.165 The second phase begins when patients are not suffering
from the effects, acute physiological or emotional, of the recent substance
abuse.166 In this phase, the goals are to prevent the patient from
relapsing, to assist the patient in developing tools to overcome or control
urges, and to help the patient regain personal health or to regain social
functioning.167 The final phase encompasses the continuing care after
treatment.168
OTTAMANELLI, supra note 152, at 158 (using data from the Minnesota Multiphasic
Personality Inventory from 1989).
158
Id.
159
McLellan, supra note 154, at 275. ―[T]here is substantial evidence that many of those
for whom the treatment system was supposedly designed do not want to participate in it.‖
Id.
160
Id.
161
Id. at 275–76.
162
Id. at 276.
163
Id.
164
Id. at 277.
165
Id.
166
Id.
167
Id.
168
Id. at 278.
157
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Studies have shown that there is a reduction in the rate of relapse
when addiction treatment works concurrently with other counseling to
address other participant issues and if ―(1) the additional service
components [are] both needed and desired by the target group; and (2)
the additional services [are] delivered at an intensity and for a duration
that is likely to be effective at reducing target problem symptoms.‖169
Given the varying complexities of each individual case, it is easy to
understand why a variety of approaches have been taken to match
patients with treatment plans.170 A final complicating factor that needs
to be considered in the context of drug courts is the significant rising
costs related to finding and providing the treatment that is necessary and
appropriate.171
B. Treatment Methods
In order to better understand substance abuse treatment, there needs
to be some knowledge of the different types of treatment options. First,
there are a number of developing and increasingly effective treatment
programs that use controlled substances to replace illicit drug use and
assist the patient in stepping down her drug use. 172
The most well-known and widely used method of pharmacological
treatment is methadone maintenance, which is largely considered
effective.173 The purpose of using methadone maintenance to treat drug
Id. at 285.
Id.
171
Id. at 286–87.
172
See id. at 282 (―Great progress has been made in the development of new medications
and in the application of existing medications for the treatment of particular conditions
associated with substance dependence and for particular types of substance-dependent
patients.‖). To further define what constitutes a ―drug,‖ it is generally considered as ―any
chemical that changes normal physiology and function in the body and in high doses
produces a toxicological or harmful effect.‖ ERICKSON, supra note 151, at 113. Additionally,
different drugs create differing levels of strength with regard to addiction. For example,
Marijuana ―has no known lethal dose in humans, making it one of the safest drugs from a
pharmacological standpoint.‖ Id. at 136.
173
Jody L. Sindelar & David E. Fiellin, Innovations in Treatment for Drug Abuse: Solutions
to a Public Health Problem, 22 ANN. REV. PUB. HEALTH 249, 252 (2001). ―Evaluations
repeatedly demonstrate that despite difficulties with retention and relapse, methadone
maintenance results in reduction in crime and drug use for those in treatment.‖ Id. See also
ERICKSON, supra note 151, at 158–59 (explaining that despite enormous agreement that it is
useful, methadone is still controversial: it is not usually an abstinence-based program of
treatment, there is a misunderstanding that methadone replaces one drug for another, and
some clinics fail to be run with strict guidelines or control); McLellan, supra note 154, at 283
(―Twenty years of studies on the effectiveness of methadone were validated by a panel of
impartial physicians and scientists in a National Institutes of Health consensus conference
that confirmed major reductions in opiate use, crime, and the spread of infectious diseases
associated with methadone maintenance.‖).
169
170
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addiction is ―to reduce drug craving, maximize the patient‘s tolerance,
and eliminate the effects of the lower potency ‗street‘ opiates.
Methadone has been used effectively as a maintenance medication
because of its slow onset of action and long half-life.‖174
There are several considerations for running a successful treatment
program that utilizes methadone maintenance. Best practices are
recommended to make sure that the patient‘s methadone use does not
become a mere replacement for the patient‘s previous substance
addiction. These practices include requiring patients to take oral
methadone tablets under observation to prevent the concealment and
reselling of the tablets on the street, regular urine testing, requiring
patients to have a job and to pay for methadone tablets, and requiring
counseling in addition to methadone maintenance.175
Additionally, there are several other medications that are currently
being used or tested in the arena of drug treatment addiction. These
include Buprenorphine and Naltrexone for opiate addictions, 176
Disulfiram for stimulant dependence, 177 and additional anticraving
drugs and abstinence-enhancing drugs that are being developed. 178
However, ―[w]hile the use of opiate and alcohol antagonists or blocking
agents is increasing as addiction medicine physicians become more
comfortable in prescribing adjunctive medications and as more
substance dependence is treated by physicians in office settings, there
are still relatively few patients who receive or physicians who prescribe
medication.‖179

McLellan, supra note 154, at 283 (parenthesis omitted).
ERICKSON, supra note 151, at 159.
176
See McLellan, supra note 154, at 283 (explaining the different applications of
Buprenorphine and Naltrexone for opiate addictions). Buprenorphine was approved in
2002 by the FDA and has few or no withdrawal symptoms, unlike methadone, and a lower
risk of overdose even if combined with other opiates. Id. Naltrexone, a drug that has been
on the market since 1984, is similar to methadone and does not produce euphoria or
disphoria but has a generally poor compliance rate. Id. Naltrexone ―may be most
useful . . . in selected populations, when combined with social, employment, or criminal
justice sanctions to increase compliance.‖ Id.
177
See id. at 284 (explaining that although most medications for stimulant dependence
―have not shown benefit compared with placebo,‖ Disulfiram is somewhat of an exception
and has been found to have an effect on cocaine abuse and, therefore, research in this area
continues).
178
See ERICKSON, supra note 151, at 174, 235 app. B (listing other drugs to treat cocaine
dependence: Disulfiram (antabuse), Gabapentin (neurontin), Modafinal (Provigil), and
Topiramate (Topamax)).
Vaccines for the treatment of nicotine, cocaine,
methamphetamine, phencyclidine, and other chemical dependencies are also being
developed. Id. at 175.
179
McLellan, supra note 154, at 284.
174
175
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Other types of treatment outside of pharmacological methods may
include different types of treatments such as placebo effects, twelve-step
programs, counseling, moderation management, faith-based treatment,
and vouchers.180 Office-based therapy is another common treatment
option. Patients who can most benefit from office-based treatment with
a psychotherapist are those individuals who are not serious abusers or
dependent, individuals seeking a harm-reduction approach, or
individuals who have had previous treatment experiences that were
unhelpful or unpleasant.181 Also, individuals who cannot work within
traditional models, individuals who have other mental health issues in
addition to substance abuse issues, individuals concerned with privacy,
individuals who want to be able to select their therapist, individuals in
early stages of addiction, individuals who have had a sustained period of
abstinence in the past, individuals who want to supplement group
therapy, individuals who want to continue therapy after completing
another program, and individuals who want to supplement a self-help
program can similarly benefit from office-based treatment.182
Another approach is the therapeutic community which consists of
―an intensive, highly structured residential, communal treatment that
operates according to a somewhat distinct, but not codified,
philosophy.‖183 The aim of the therapeutic community is to get abusers
to develop a sense of self-help via a structured reward system and a
reality-based approach.184
Some drug addictions cause such massive damage to the drug
abuser that drug addiction treatment alone will not be sufficient. For
example, in the case of methamphetamine addictions, treatment may
also require addressing a host of other medical conditions including:
neurological damage, cardiovascular damage, respiratory damage,
infectious diseases (HIV/AIDS, STDs, Hepatitis C), dental damage,
dermatological damage, methamphetamine psychosis, and cognitive
impairment.185 As illustrated, the full scope of treatment for some users
will go far beyond the treatment of the addiction alone. Because of this,
in part, ―[t]here is no uniformly held standard, or even clear consensus,
180
ERICKSON, supra note 151, at 152–56, 162–64. In a voucher program, patients receive a
voucher for each week they are drug free—obsession for reward replaces obsession for
drug. Id. at 164.
181
WASHTON & ZWEBEN, supra note 149, at 15–16.
182
Id.
183
Sindelar & Fiellin, supra note 173, at 254.
184
Id.
185
Kathleen M. Carroll & Samuel A. Ball, Assessment of Cocaine Abuse and Dependence, in
ASSESSMENT OF ADDICTIVE BEHAVIORS 199–205 (Dennis M. Donovan & G. Alan Marlatt eds.,
2d ed. 2005).
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regarding an ideal treatment outcome indicator or definition of
treatment success in [drug] abuse treatment. Although definitions of
success are broadening beyond requiring complete abstinence from
[drug use], meaningful reductions in [drug] use remain a central
indicator of improvement.‖186
C. The Abstinence Model
As mentioned in Section II, drug courts in the United States largely
follow an abstinence model of drug treatment. This is a blunt approach.
In essence, the drug courts take an all or nothing attitude towards
treatment. When following an abstinence model, ―[a]bstinence . . . is
both a key element of treatment and an ultimate goal of most treatment
programs.‖187 To meet this end, urine testing is a common practice in
drug treatment court.188 The goal of the treatment program is clear and
measurable: when the user is no longer using, the program is complete.
The abstinence model is not without its difficulties. As outlined above,
drug treatment often entails navigating a complicated maze of issues
that fall both inside and outside the realm of addiction.
When abstinence from drug use during and after treatment is the
main goal of the treatment program, there is more room for failure to
address the underlying problems at the root of the drug addiction.
Additionally, because addiction is a disease, a complete abstinence
approach may not be the long-term goal for every drug addict.189
Additionally, some scientists have observed a mental obstacle to
successful completion of treatment in abstinence-based therapies. This is
called the Abstinence Violation Effect, which is a ―cognitive-affective
reaction to an initial slip that increases the probability that the lapse will
be followed by an increased use of the substance or activity.‖ 190 In other
words, once the user falls off the wagon once, he is more inclined to have
an increase in use or have additional uses of the drug in the future.
D. The Harm-Reduction Model
―Harm reduction is a public health approach intended to reduce the
harm done to alcohol and drug users, their loved ones, and
Id. at 167 (citation omitted).
Hora & Stalcup, supra note 1, at 761.
188
Id. at 755–56.
189
Elizabeth Zelvin & Diane Rae Davis, Harm Reduction and Abstinence Based Recovery: A
Dialogue, 1 J. SOC. WORK PRAC. ADDICTIONS 121, 122 (2001).
190
MARGOLIS & ZWEBEN, supra note 155, at 272 (quoting RELAPSE PREVENTION:
MAINTENANCE STRATEGIES IN THE TREATMENT OF ADDICTIVE BEHAVIORS 179 (G. Alan
Marlatt & Judith R. Gordon eds., 1985)).
186
187
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communities.‖191 On the whole, the harm-reduction model looks to
make the user ―whole‖ in terms of the quality of life that he may achieve
without the interference of drug addiction. ―Harm reduction has often
been described as being technically the antithesis of abstinence-based
substance abuse treatment despite the fact that there is a great deal
technically in common within these theoretical contexts.‖192 Although
both methods aim to achieve freedom from drug addiction, the means
for achieving this freedom and the definition of freedom may vary
greatly between the treatment models. The main difference in the
models is that the abstinence-based model requires complete abstinence
as a requirement to be in treatment and as the goal of treatment. Harmreduction models can be more flexible to where the patient is in her stage
of addiction or abuse and can be adjusted if it is not working. 193 ―Harm
reduction recognizes abstinence as an ideal outcome, but accepts
alternatives to reduce harm.‖194 Ultimately, the goal in harm reduction is
to ―reduce the negative effects on a patient‘s life of his or her misuse of
substances.‖195
There is a lot of support for the harm-reduction philosophy in the
treatment of drug addiction.196
Benefits of the harm-reduction
philosophy include the creation of ―a comfortable, respectful atmosphere
in which patients can connect to the program as a whole which goes a
long way toward solving one of the most consistent problems of
substance abuse treatment: patient retention.‖ 197 Additionally, this leads
to a strong sense of community in the program and patients feel that it is
safe to return to the program even if they relapse because they will not
be punished for a relapse.198
Id. at 8. Some examples of harm-reduction strategies include the following: (1)
―Education of the public about the dangers of drunk driving‖; (2) ―[m]ethadone
[m]aintenance‖—other substitution therapy; (3) ―[n]eedle-exchange programs‖; and (4)
―[t]eaching ‗alcoholics‘ to drink socially or in moderation.‖ ERICKSON, supra note 151, at
161–62 (emphasis omitted).
192
Roy Futterman, Maria Lorente & Susan Silverman, Integrating Harm Reduction and
Abstinence-Based Substance Abuse Treatment in the Public Sector, 25 SUBSTANCE ABUSE 3, 3
(2004) (footnotes omitted).
193
Zelvin & Davis, supra note 189, at 125. Harm reduction allows a patient to start where
a person is—even if they are not ready to give up drug use. Id.
194
Id. at 124.
195
Futterman, Lorente & Silverman, supra note 192, at 3.
196
Id. Harm reduction as a treatment for substance abuse ―has been one of the most
fruitful developments in the theory and technique of substance abuse treatment, emerging
from the integration of the formerly disconnected world of psychology along with the
related techniques of relapse prevention and motivational interviewing.‖ Id. (footnotes
omitted).
197
Id. at 5.
198
Id. at 6.
191
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In the context of coerced treatment, harm-reduction models seem to
create a greater likelihood of success than abstinence programs.
―Mandated patients who arrive [in a harm-reduction program] initially
with predominately external reasons to be in treatment respond well to
the relaxed but structured attitude of harm reduction treatment.‖ 199 One
of the reasons that this may be the case is that harm reduction includes
motivational interviewing as a part of the treatment program.
Motivational interviewing may identify internal motivators for ending
substance use, which helps mandated patients become more invested in
the treatment.200 Greater investment in harm-reduction programs may
also result from the fact that ―[h]arm reduction . . . [is] a ‗bottom-up‘
approach based on addict advocacy rather than a ‗top-down‘ policy
promoted by drug-policy makers.‖201
The harm-reduction model might be more easily adopted
internationally than in the United States. This may be due to the fact that
other countries have adopted a more accepting view of what constitutes
a drug user.
Instead of a strung-out, hung-over, untrustworthy, in
denial, incapable of making decisions type of individual,
they found individuals with a capacity to educate others
and be educated, to form organizations, to manage
funding, to represent their community, to serve on
governmental consultative committees, and employable
in a variety of roles while actively using drugs. 202
This redefinition of the drug user exemplifies the basic tenets of
compassionate pragmatism that form the basis for the harm-reduction
model, as opposed to holding drug users up to a moralistic ideal. 203
Finally, there is also some statistical evidence that harm-reduction
treatment models are over seventy percent more effective than treatment
based on abstinence alone.204

Id.
Id. at 6–7.
201
Zelvin & Davis, supra note 189, at 124.
202
Id. at 125. Countries such as England, Switzerland, The Netherlands, Canada,
Australia, and New Zealand have found the benefits of grass-roots involvement in drug
rehabilitation, including a redefining of the way a drug user is perceived. Id.
203
Id.
204
See Anna E. Saxman, The President’s Column, 30 VT. BAR J. 3 (Summer 2004).
―Information from the Commissioner of Health, Paul Jarris, demonstrated that medically
assisted treatment effectiveness ranges between 85 and 90 percent; by comparison,
treatment based on abstinence is only 15 percent effective.‖
199
200
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E. Integration of Abstinence and Harm-Reduction Models
A harm-reduction strategy may seem to be antithetical to abstinencebased programs.205 However, harm-reduction strategies can co-exist
with abstinence models.206
Not only that, but ―mixed-modality
programs have shown promise in bettering outcomes.‖ 207 Given these
reasons, a comprehensive approach seems the most likely to achieve
success.208
In fact, some integrated models do exist. In these programs,
substance use may be allowed during treatment, while complete
abstinence remains the ultimate goal. 209 For example, under a treatment
model that includes methadone therapy, the user will eventually
stabilize and be able to function normally. 210 However, some users will
continue to be methadone dependent and therefore, not technically drug
free.211 While the goal is to wean the user from all drug use, including
methadone, the use of methadone will not be a bar to the patient‘s
successful completion of a treatment program. In these mixed-modality
models, it is important to remember that although abstinence is one goal
for the treatment of drug abusers, another key goal is to ―produce lawabiding individuals who maintain control over their behavior.‖ 212
V. CONCLUSION: WHAT‘S NEXT FOR THE UNITED STATES?
To begin this discussion, it should be emphasized that drug courts in
the United States were developed because the traditional court models
were overloaded with cases involving drug offenders; thus, an
alternative model was necessary to deal with this problem. The drug
court model has been successful at providing an alternative means for
dealing with drug related cases. In the United States and internationally,
drug courts seem to increase the retention of drug abusers in treatment
and reduce drug use and criminal behavior while abusers are in

ERICKSON, supra note 151, at 161.
MARGOLIS & ZWEBEN, supra note 155, at 8.
207
M. Douglas Anglin & Yih-Ing Hser, Treatment of Drug Abuse, 13 CRIME & JUST. 393, 395
(1990).
208
Barry Stimmel, From Addiction to Abstinence: Maximizing the Chances of Success, 47 FAM.
CT. REV. 265, 272 (2009).
209
Futterman, Lorente & Silverman, supra note 192, at 4 (examining a program at the
Growth and Recovery Program in North Central Bronx Hospital and Jacobi Medical Center
in New York City).
210
MARGOLIS & ZWEBEN, supra note 155, at 137–38.
211
See id. at 137 (explaining that a long-term dose of methadone is substituted for shortterm illicit drug use).
212
Hora & Stalcup, supra note 1, at 733.
205
206
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treatment.213 ―The connection between drug abuse and crime is well
known.‖214 When drug abuse goes untreated, offenders are more likely
to relapse to drug abuse and return to criminal behavior. 215
Furthermore, basic tenets of drug treatment suggest that rewarding
substance abusers for positive behavior is more effective than submitting
substance abusers to punishment for negative behavior. 216 Finally,
―[d]rug abuse treatment is cost effective in reducing drug use and
bringing about associated healthcare, crime, and incarceration cost
savings.‖217
On the basis of these foundational principles, drug courts seem to be
a program worth continuing in the future. However, the system of drug
courts in the United States could take a few lessons from the
international models and from the lessons learned by professionals in the
field of drug treatment.
First, drug courts in the United States should not be as quick to form
as they have been over the past two decades. Several countries,
particularly Canada and the United Kingdom, have found success when
opening drug courts by using a series of dedicated drug courts as pilot
programs. These programs tested various aspects of a potential drug
court program in a limited area before expanding on a broader level.
The result of this careful and pragmatic implementation is that each new
drug court could learn from the previous courts. The dedicated drug
court could more effectively serve the population in the geographic area
where it was situated, determine the areas (both geographically and in
terms of treatment and training) of greatest need, and determine the
types of participants that were likely to be served. This planning aided
in the acquisition of the proper training, accommodations, and resources
to implement the court once it was established. One thing that we can
learn from the United Kingdom‘s observations of the dedicated drug
courts pilot is that ―[d]iversion from criminal justice into treatment
requires effective multidisciplinary and inter-agency working, but this
was a weak spot in treatment provision.‖218
213
See Sindelar & Fiellin, supra note 173, at 260; see also Marlowe, supra note 32, at 7 (―The
evidence is clear that drug courts can increase clients‘ exposure to treatment.‖).
214
NATIONAL INSTITUTE ON DRUG ABUSE, U.S. DEP‘T OF HEALTH & HUM. SERVS., PUB. NO.
06–5316, PRINCIPLES OF DRUG ABUSE TREATMENT FOR CRIMINAL JUSTICE POPULATIONS: A
RESEARCH-BASED GUIDE 12 (2006) (emphasis omitted).
215
Id. at 13.
216
Id. at 21.
217
Id. at 26.
218
Mary McMurran, What Works in Substance Misuse Treatments for Offenders?, 17 CRIM.
BEHAVIOUR & MENTAL HEALTH 225, 229 (2007). Reconviction was significantly less likely
amongst those who completed their diversion programs (fifty-three percent) than those
whose orders were revoked. Id.
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While the number of drug courts that are currently operating in the
United States is impressive, the quality may be improved if we allocated
resources to the study and observation of existing drug courts to
determine what techniques or practices are most effective in serving the
populations. This may aid in the planning and development of more
efficient and successful drug courts in the future.
The next important change to drug courts in the United States would
be to move toward a model of treatment that is more in line with a harmreduction approach. Not only do professionals in the field of addiction
treatment view this as a more effective model for drug treatment, but
also it is a widely used model in drug courts internationally. The United
States is unlikely to adopt a pure harm-reduction model for a number of
reasons. The chief reason is that use of any illegal drug cannot be
condoned by the criminal justice system. 219 However, recognition that
addiction is a disease and that it is difficult to overcome should allow the
courts to move toward a model where abstinence is the ultimate goal
and harm reduction is the operating model during treatment.220
Arguably, the courts are already operating in this model. Some drug use
during treatment will not usually result in the participant being thrown
out of the program.
However, the current model may impose
punishments on those individuals who do slip up. This negative
enforcement is not the most effective means of treatment and would be
removed in mixed-modality treatment program.
Additionally, if the United States truly views drug courts as a means
to combat the growing problem of drugs in society, it needs to use the
approach that is most likely to result in successful treatment for a user‘s
drug addiction. This means that the users need to be viewed as a whole.
All parts of the user‘s life must be considered to help bring the user back
to a level where she functions effectively in society. What is the value of
success when a person abstains from drug use for a mandated period of
time and then relapses shortly after completion of her sentence? It
would be more beneficial to our society to have individuals who are able
to function and contribute, even if that means those individuals have an
occasional drug habit that they are continuing to treat and control.
There are several arguments that the use of less dangerous drugs, such as marijuana,
should be legalized and/or that monitored use of controlled substances could be legal;
however, those are issues for another article.
220
Another option is to create an alternative to drug courts, such as a coerced abstinence
program. Sindelar & Fiellin, supra note 173, at 260. This program would allow ―early
release of some drug-abusing, nonviolent prisoners to a probation program that frequently
tests for drug abuse.‖ Id. However, if courts revert back to this model, it would not likely
be any more effective than the expedited drug case management system that the drug
treatment court model rejects.
219
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Another frustrating challenge is that despite its effectiveness,
addiction medications are not frequently used to treat users within the
criminal justice system.221 The science of addiction and medicine is a
growing field. More and more medications are being developed to treat
and prevent addictions. Although the cost may be a concern, the judicial
system should not ignore the significant treatment options that are
presented in a pharmacological treatment regimen.
Although the rising costs of drug courts and the depressing state of
the economy will continue to serve as excuses for not funding drug
courts or for not adopting more effective methods of treatment, 222 they
should not be the stumbling blocks that bring the progress and
development of drug courts in the United States to a halt. 223 From a
fiscal standpoint, drug courts are better than continuing to lock people
up.224 This not only does a disservice to those who need treatment, but
also to all those who foot the bill for the results of failure to provide this

221
See NATIONAL INSTITUTE ON DRUG ABUSE, supra note 214, at 23 (―Despite evidence of
their effectiveness, addiction medications are underutilized in the treatment of drug
abusers within the criminal justice system. Still, some jurisdictions have found ways to
successfully implement medication therapy for drug abusing offenders.‖).
222
Report Urges Expansion of Inmate Substance Abuse Treatment Programs, 15 CORRECTIONS
PROF., no. 10, March 1, 2010.―‗States complain mightily about their rising prison costs,‘ said
Susan E. Foster, CASA‘s vice president and director of policy research and analysis. ‗Yet
they continue to hemorrhage public funds that could be saved if they provided treatment
to inmates with alcohol and other drug problems and stepped up use of drug courts and
prosecutorial drug treatment alternative programs.‘‖ Id. Indeed, some jurisdictions cannot
even cling to these excuses. In Minnesota, for example, hope is not lost despite the bleak
economic situation facing the courts. Attorney General Eric H. Holder says that he will
continue to find more effective ways to deal with nonviolent drug crimes, including drug
courts. James Podgers, Holder Speech Highlights ABAB Annual Meeting: New Attorney
General Says Administration Will Seek “Smart” Strategies to Address Crime, 95 A.B.A. J. 63
(Sept. 2009). Perhaps there are also some means of creative financing that courts can
explore. See Hora, Schma & Rosenthal, supra note 1, at 511–12 (describing different
methods of funding for drug courts).
223
There may be other challenges to drug courts in the United States and abroad. One
particular challenge that faces the courts is the treatment of minorities and determining if
the current system fails in this respect. There are mixed views on this point. See Bowers,
supra note 21, at 807 (discussing how minorities are more frequently terminated from drug
courts than their white counterparts); Wright, supra note 2, at 79–80 (noting that more
minorities are arrested for drug use than whites and pointing out the bias against
minorities in the court sentencing structure). If so, what does this mean for populations in
other cultures such as the Maori in New Zealand or the Aborigine in Australia? Is there
room for drug courts in cultures where the structure of the court systems is varied (i.e.
African tribal courts—there may be some potential in this area as there are a number of
tribal courts in the United States as well as aboriginal courts in Australia)?
224
See Jane Pribek, Wisconsin Attorney Hon. M. Joseph Donald: Offenders Reform in New
Drug Court, WISC. L. J., March 8, 2010; see also Hora & Stalcup, supra note 1, at 765–66
(providing statistics on the success of drug courts).
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treatment. In a report issued by The National Center on Addiction and
Substance Abuse at Columbia University, the study
found that while 65 percent of inmates meet the medical
criteria for substance abuse addiction, only 11 percent
receive any treatment. Researchers concluded that if all
inmates who needed treatment and aftercare received
such services, the nation would break even in one year if
a little more than 10 percent remained substance free,
crime free and employed.225
―Because addiction is a disease that most medical professionals agree
cannot be overcome by self-will alone, merely incarcerating substance
abusers or placing them on probation without treatment fails to treat the
disease and invites the inevitability of recidivism.‖226
After twenty years, the score is not completely settled with respect to
drug courts in the United States. While they have continually grown in
number and efforts have been undertaken to help in the effective
operation, there are significant changes that will improve the
effectiveness of drug courts in the United States. Taking a cue from its
international counterparts and from the field of drug treatment, the
United States should consider shifting its model of treatment away from
a purely abstinence-based approach toward a harm-reduction approach.
Additionally, following in the footsteps of several of the international
drug courts, the United States should slow the growth of drug courts
and spend more time evaluating and observing the operation of its drug
courts. Doing so will help to improve the quality of the existing drug
courts and aid in the creation and development of drug courts in the
future.
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https://scholar.valpo.edu/vulr/vol45/iss1/4

CORRECTIONS PROF., supra note 222.
Hora & Stalcup, supra note 1, at 724.

